摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(+)-monanchorin TFA Salt | 1120352-15-9

中文名称
——
中文别名
——
英文名称
(+)-monanchorin TFA Salt
英文别名
(1R,5R,7S)-7-pentyl-6-oxa-2,4-diazabicyclo[3.2.2]non-3-en-3-amine;2,2,2-trifluoroacetic acid
(+)-monanchorin TFA Salt化学式
CAS
1120352-15-9
化学式
C2HF3O2*C11H21N3O
mdl
——
分子量
325.331
InChiKey
FJPCSZCESXMPNC-YMQJAAJZSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.85
  • 拓扑面积:
    96.9
  • 氢给体数:
    3
  • 氢受体数:
    7

反应信息

  • 作为产物:
    描述:
    三氟乙酸二氯甲烷 为溶剂, 反应 96.0h, 以130 mg的产率得到(+)-monanchorin TFA Salt
    参考文献:
    名称:
    A New Stereocontrolled Total Synthesis of the Mast Cell Inhibitory Alkaloid, (+)-Monanchorin, via the Wittig Reaction of a Stabilized Ylide with a Cyclic Guanidine Hemiaminal
    摘要:
    An asymmetric total synthesis of the mast cell inhibitor (+)-monanchorin is reported in which a Sharpless AD on 11 and a cyclic sulfate ring opening with an azide feature as key steps. After further manipulation, a novel guanidine-controlled ester reduction provided the guanidine-hemiaminal 25 which underwent Wittig olefination to give 27. Hydrogenation and a second guanidine-controlled reduction of the ester in 28, to obtain aldehyde 29, then set up a trifluoroacetic acid mediated cyclization to give (+)-monanchorin TFA salt.
    DOI:
    10.1021/ol500616v
点击查看最新优质反应信息

文献信息

  • <i>De Novo</i> Asymmetric Synthesis of (+)-Monanchorin
    作者:Yuzhi Ma、George A. O’Doherty
    DOI:10.1021/acs.orglett.5b02651
    日期:2015.11.6
    A de novo asymmetric total synthesis of the guanidine alkaloid natural product (+)-monanchorin has been achieved in nine steps from the commodity chemicals furan and caproic acid. The asymmetry of the route was introduced by a Noyori reduction of an acylfuran. In addition, this route relies upon an Achmatowicz rearrangement, a diastereoselective palladium catalyzed glycosylation, reductive amination, and an acid catalyzed bicyclic guanidine mixed acetal formation.
  • Synthesis of (+)- and (−)-Monanchorin
    作者:Min Yu、Barry B. Snider
    DOI:10.1021/ol802981h
    日期:2009.2.19
    The optically pure epoxy acetal was converted to the protected guanidino alcohol by reaction with NaN3 in DMF, hydrogenation of the azide, and reaction of the amine with MeSC(NBoc)NHBoc, AgNO3, and Et3N. Treatment of the protected guanidino alcohol with 9:1 CDCl3/TFA afforded monanchorin, whose absolute stereochemistry was assigned as shown.
  • A New Stereocontrolled Total Synthesis of the Mast Cell Inhibitory Alkaloid, (+)-Monanchorin, via the Wittig Reaction of a Stabilized Ylide with a Cyclic Guanidine Hemiaminal
    作者:Karl J. Hale、Liping Wang
    DOI:10.1021/ol500616v
    日期:2014.4.18
    An asymmetric total synthesis of the mast cell inhibitor (+)-monanchorin is reported in which a Sharpless AD on 11 and a cyclic sulfate ring opening with an azide feature as key steps. After further manipulation, a novel guanidine-controlled ester reduction provided the guanidine-hemiaminal 25 which underwent Wittig olefination to give 27. Hydrogenation and a second guanidine-controlled reduction of the ester in 28, to obtain aldehyde 29, then set up a trifluoroacetic acid mediated cyclization to give (+)-monanchorin TFA salt.
查看更多

同类化合物

雷唑巴占 唑美巴占 六氢-2-(硝基亚氨基)-1H-1,3-二氮杂卓 [1,3]恶唑并[3,2-a][1,3]二氮杂卓 7-苯基-3,4-二氢-1H-1,4-二氮杂革-5(2H)-酮 7,8-二氢-1-苯基-6H-吡啶并(3,2,1-jk)(1,4)苯并二氮杂卓-4(3H)-酮 5H-吡咯并[1,2-a][1,4]二氮杂卓 5-甲基-7-苯基-6,7-二氢-1H-1,4-二氮杂-2,3-二甲腈 5-三氟甲基-2,3-二氢-1H-1,4-二氮杂卓 5,7-二苯基-2,3,6,7-四氢-1H-1,4-二氮杂卓 5,7-二甲基-2,3-二氢-1H-[1,4]二氮杂卓高氯酸盐 4,5,6,7-四氢-1H-1,3-二氮杂卓-2-胺 3,5,7-三苯基-4H-1,2-二氮杂卓 2H-[1,3,5]恶二嗪o[3,2-a][1,3]二氮杂卓 2-甲基硫代-4,5,6,7-四氢-1H-[1,3]二氮杂卓 2-甲基-4,5,6,7-四氢-1H-1,3-二氮杂卓 2,3-二氢-5,7-双(三氟甲基)-1H-1,4-二氮杂卓 1-(5-甲氧基-1,4-二氮杂-1-基)乙酮 1,4,5,7,8,9,10,10A-八氢吡啶并[1,2-a][1,4]二氮杂卓 (9ci)-2,3-二氢-N,N-二甲基-1H-1,4-二氮杂卓-6-甲胺 (9ci)-1H-1,2-二氮杂卓-1-羧酸甲酯 (9ci)-1H,3h-噁唑并[3,4-d][1,4]二氮杂卓 (9ci)-1H,3h-噁唑并[3,4-a][1,4]二氮杂卓 1,7-di-(4-chlorophenyl)-3a,4a-dimethyl-3a,4a,8,13-tetrahydro-4H-bis[1,2,4-oxadiazolo][4,5-a:5',4'-d][1,5]benzodiazepine [1,4]diazepine-1-carboxylic acid tert-butyl ester 6-o-Chlorophenyl-8-ethyl-1,2-dihydro-4H-s-triazolo [3,4-c] thieno[2,3-e] [1,4]diazepin-1-one 2-(2-Dimethylaminoethyl)-6-o-chlorophenyl-8-ethyl-1,2-dihydro-4H-s-triazolo[3,4-c]thieno[2,3-e][1,4]diazepin-1-one 2-methyl-5-trifluoromethyl-2,3-dihydro-1,4-diazepine 3-methyl-5-trifluoromethyl-2,3-dihydro-1,4-diazepine 2,3-dihydro-2-methyl-6-nitro-1H-1,4-diazepine 1,4-dimethyl-7-((2,2-dimethylpropyl)amino)-1,2,3,4-tetrahydro-5H-1,4-diazepin-5-one 9-cetyl-3-methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]diazepinium bromide Methyl 3,7-Diazabicyclo[5,4,0]undec-5-ene 1-N-tert-butoxycarbonyl-3-methoxy-6,6-dimethyl-1,4-diazepine trans-5,9a-dimethyl-5a,6,7,8,9,9a-hexahydro-1H-benzo[e]-1,4-diazepine-2,3-dicarbonitrile 2,3,4,5,7,9-hexahydro-9-methyl-9-(N-p-chlorophenylthio-carbamoyl)-[1,3]oxazolo[3,4-a][1,3]diazepin-7-one 2,3,4,5,7,9-hexahydro-9-methyl-9-(N-phenylthio-carbamoyl)-[1,3]oxazolo[3,4-a][1,3]diazepin-7-one 1,5-diazabicyclo [5.4.0] undecene 4,5,6,7-tetrahydro-2[2-(pyridin-4-yl)ethyl]-1H-1,3-diazepine 1,3-diazepane-2-selenone 2-[3]pyridyl-4,5,6,7-tetrahydro-1H-[1,3]diazepine 4,6-bis(trifluoromethyl)-2-isopropoxy-1H-1,3-diazepine 3-Methyl-8-(2-fluorophenyl)isoxazolo[4,3-e][1,4]-diazepin-5-one 4-(2-Diethylaminoethyl)-8-(2-fluorophenyl)-3-methylisoxazolo-[4,3-e][1,4]diazepin-5-one 2,3a,5,5-tetramethyl-3a,4,5,6-tetrahydrothiazolo[3,2-a][1,5]-benzodiazepin-1(2H)-one pyrrolo[1,2-a][1,4]diazepine 2H-1,3-Diazepine 36KJ536Yay N-octadecyl-4,5,6,7-tetrahydro-1H-1,3-diazepin-2-amine;hydroiodide N-decyl-4,5,6,7-tetrahydro-1H-1,3-diazepin-2-amine;hydroiodide